![]() |
|||||||||||||||||
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||
|
![]() |
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 10, Number 3, March 2004 Clinical Trials and Novel Pathogens: Lessons Learned from SARSMatthew P. Muller,*‡ Allison McGeer,*‡ Sharon E. Straus,†‡ Laura Hawryluck,†‡
and Wayne L. Gold†‡ |
|
|
![]() |
|
Back to article | |
Figure. Epidemic curve of the first Toronto SARS outbreak. Data provided courtesy of the Ministry of Health and Long Term Care, Ontario, Canada. |
|
|
|
![]() |
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
![]() |
![]() |
This page last reviewed February 2, 2004 |
![]() |
![]() |
Emerging
Infectious Diseases Journal |
![]() |